Arca Biopharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABIO Nasdaq 2834 http://arcabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arca Biopharma Inc

ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial - Sep 18th, 2018 6:30 am
ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update - Aug 9th, 2018 2:15 pm
Marijuana Stocks: Biotech Stock Report: 3 Companies To Watch In August 2018 - Aug 3rd, 2018 7:45 am
3 Biotech Stocks in Focus on Tuesday - Jul 31st, 2018 10:15 am
ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation - Jul 31st, 2018 6:30 am
Today’s Research Reports on Stocks to Watch: Progenics Pharmaceuticals and Arca Biopharma - Jul 31st, 2018 6:10 am
Breakfast Technical Briefing on Alkermes and Three Other Additional Biotech Stocks - Jun 19th, 2018 5:05 am
Today’s Research Reports on Stocks to Watch: vTv Therapeutics and ARCA Biopharma - May 11th, 2018 6:20 am
Free Technical Insights on Aimmune Therapeutics and Three More Biotech Stocks - May 10th, 2018 5:15 am
Blog Exposure - Insmed Announced Submission of New Drug to FDA for Patients with Nontuberculous Mycobacterial Lung Disease - Apr 3rd, 2018 5:20 am
Here’s Why Arca Biopharma Inc (ABIO) Shares Are Skyrocketing Today - Feb 27th, 2018 1:00 pm
ARCA biopharma And ObsEva Just Put Out Clinical Trial Data - Feb 26th, 2018 12:18 pm
One Thing To Consider Before Buying ARCA biopharma Inc (NASDAQ:ABIO) - Jan 23rd, 2018 3:13 pm